Cargando…

Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI

BACKGROUND: Whether the underlying risk of high bleeding risk (HBR) influences the relationship of high thrombotic risk (HTR) features with adverse events after drug-eluting stent implantation remains unclear. The purpose of this study was to evaluate (1) the prognostic effect of ESC guideline-endor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hao-Yu, Dou, Ke-Fei, Yin, Dong, Zhang, Dong, Gao, Run-Lin, Yang, Yue-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329419/ https://www.ncbi.nlm.nih.gov/pubmed/32611318 http://dx.doi.org/10.1186/s12872-020-01600-3

Ejemplares similares

Prognostic and Practical Validation of ESC/EACTS High Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in Contemporary PCI Patients
por: Wang, Hao-Yu, et al.
Publicado: (2022)

Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
por: Dannenberg, Lisa, et al.
Publicado: (2021)

Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
por: Yamamoto, Ko, et al.
Publicado: (2023)

Letter to the Editor: How Should We Treat High-risk Patients in the Chronic Phase Following PCI: Clopidogrel or Prolonged DAPT?
por: Wang, Hao-Yu, et al.
Publicado: (2021)

Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI
por: Wang, Hao-Yu, et al.
Publicado: (2022)

Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era
por: Mahajan, Kunal, et al.
Publicado: (2020)

Performance of DAPT Score and ESC Criteria for Predicting Clinical Outcomes in Chinese Patients with Acute Coronary Syndrome
por: Deng, Tianhua, et al.
Publicado: (2023)

Incidence, predictors, and outcomes of DAPT non-compliance in planned vs. ad hoc PCI in chronic coronary syndrome
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Correlation Between the Japanese Version of the High Bleeding Risk (J-HBR) Criteria and the PRECISE-DAPT Score, and Optimal J-HBR Cut-Off Score to Predict Major Bleeding
por: Kubota, Naoki, et al.
Publicado: (2022)

Balancing Between Ischemic and Bleeding Risk in PCI Patients With ‘Bi-Risk’
por: Park, Mahn-Won
Publicado: (2022)

Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome
por: Long, Tianyi, et al.
Publicado: (2018)

Heyde’s Syndrome Complicating Management in a Patient With High Bleeding and Thrombotic Risks
por: Ahmed, Talha, et al.
Publicado: (2020)

Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events
por: Kawashima, Hideyuki, et al.
Publicado: (2020)

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
por: Dong, Liang, et al.
Publicado: (2022)

Triple therapy after PCI – Warfarin treatment quality and bleeding risk
por: Wadell, Daniel, et al.
Publicado: (2018)

Practical Assessment of the Tradeoff between Fatal Bleeding and Coronary Thrombotic Risks using the Academic Research Consortium for High Bleeding Risk Criteria
por: Sotomi, Yohei, et al.
Publicado: (2022)

Short-term DAPT after coronary stenting has similar ischemic and bleeding outcomes as long-term DAPT: a 5-year population-based cohort study
por: Balaji Srinivasan, Sriraag, et al.
Publicado: (2022)

European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and Haemostasis: A European Renal Best Practice (ERBP) endorsement of ISTH Guidelines for Treatment of Thrombotic Thrombocytopaenic Purpura (TTP) with some refinements for Europe
por: Eller, Kathrin, et al.
Publicado: (2022)

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018)

The Cornelian dilemma(†) of quitting DAPT
por: Motovska, Zuzana, et al.
Publicado: (2021)

Contradictions between DAPT and PRECISE-DAPT scores with the severity of coronary lesion in acute coronary syndrome
por: Bi, Sisi, et al.
Publicado: (2020)

Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019)
por: Mezier, A., et al.
Publicado: (2023)

The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence
por: Zhang, Shuqi, et al.
Publicado: (2022)

Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study
por: Wang, Hao-Yu, et al.
Publicado: (2020)

Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
por: Schäfer, Andreas, et al.
Publicado: (2020)

Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
por: Elsinga, Philip, et al.
Publicado: (2019)

Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
por: Elsinga, Philip, et al.
Publicado: (2019)

Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
por: Elsinga, Philip, et al.
Publicado: (2019)

Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
por: Elsinga, Philip, et al.
Publicado: (2019)

Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration
por: Toyota, Toshiaki, et al.
Publicado: (2017)

Mechanical circulatory support in high-risk PCI and acute coronary syndrome
por: Pappalardo, Federico, et al.
Publicado: (2017)

Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index
por: Dobies, David R, et al.
Publicado: (2015)

Which One to Endorse Among the Multitude of Lipid Guidelines?
por: Sonmez, Alper
Publicado: (2015)

IFCN-endorsed practical guidelines for clinical magnetoencephalography (MEG)
por: Hari, Riitta, et al.
Publicado: (2018)

Abbreviated lipid guidelines for clinical practice: Based on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021
por: Maher, Vincent, et al.
Publicado: (2023)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

Thrombosis and Major Bleeding Risk After Primary PCI Among Patients With Multivessel Coronary Artery Disease
por: Zhao, Xiaoxiao, et al.
Publicado: (2022)

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
por: Pufulete, Maria, et al.
Publicado: (2022)

Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk
por: Park, Keun-Ho, et al.
Publicado: (2021)

A comparison of safety and efficacy between long-term DAPT and intensive statins combined with short-term DAPT for acute ischemic stroke
por: Deng, Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d87dq6kvgme75i1kbva66pvhbp